Cat. No. | Product name | CAS No. |
DC60609 |
AK59-51TB (AK59)
Featured
AK59-51TB (AK59) is a STING degrader leveraging HERC4, a HECT-domain E3 ligase. |
|
DC60610 |
IDE397
Featured
IDE397 is a potent inhibitor of MAT2A, which is developed to selectively exploit this synthetic lethal vulnerability in MTAP−/− tumors. |
|
DC60611 |
Compound 32 (HER2)
Featured
Compound 32 (HER2) is a potent and selective covalent inhibitor of HER2/WT and HER2/YVMA with IC50 of 49 nM and 42 nM, respectively. |
|
DC60612 |
IDOR-1117-2520
Featured
IDOR-1117-2520 is a selective and insurmountable antagonist of CCR6 with IC50 of 20 nM. |
|
DC66543 |
Pidobenzone
Featured
Pidobenzone is a dermatologic agent. |
138506-45-3 |
DC66544 |
Pseudouridine 5'-triphosphate trisodium
Featured
Pseudouridine-5’-triphosphate (Pseudo-UTP) is one of the most commonly used modified nucleoside for the polymerase-mediated synthesis of RNA molecules. Compared with uridine-containing unmodified mRNAs, the application of pseudouridine-containing modified mRNAs exhibits better nuclease stability, immunogenicity, and translational properties. |
|
DC66545 | 5-Bromo Brassinin Featured | 1076199-55-7 |
DC60613 |
LSN3441732
Featured
LSN3441732 is a dimeric compound and inhibits the formation of Lipoprotein(a) (Lp(a)) particles in vitro with IC50 of 0.18 nM. |
|
DC66546 |
R-Sirpiglenastat
Featured
R-Sirpiglenastat is the R- isomer of Sirpiglenastat(DRP-104).Sirpiglenastat (DRP104) is a broad acting glutamine antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response. |
|
DC66547 | SL25 intermediate 16 Featured | 185835-91-0 |
DC60614 |
BIO-8169
Featured
BIO-8169 is a highly potent, selective, and brain-penetrant IRAK4 inhibitor with IC50 of 0.2 nM. BIO-8169 has an excellent PK profile, reduces the in vivo production of pro-inflammatory cytokines, and is tolerated in toxicity studies in rodents and dogs. |
|
DC60615 |
Nelutroctiv (CK-136)
Featured
Nelutroctiv (CK-136) is a novel cardiac troponin activator devoid of PDE-3 activity that demonstrates a wider pharmacodynamic window in vivo relative to a representative myosin activator, CK-138. |
|
DC60616 |
TERT activator compound tac
Featured
TAC is a TERT activator compound that upregulates TERT transcription via the MEK/ERK/AP-1 cascade. TAC alleviates neuroinflammation, increases neurotrophic factors, stimulates adult neurogenesis, and preserves cognitive function without evident toxicity, including cancer risk. |
|
DC66548 | GalNAc-Lipid GL3 Featured | |
DC66549 | GalNAc-NAG-37 Phosphoramidite Featured | |
DC66550 | GalNAc-Cluster-COOH Featured | |
DC66551 | GalNAc-Cluster-HHA-CE Phosphoramidite Featured | |
DC66552 | PAM-Acid derivatives Featured | |
DC66553 | PAM-Acid Featured | |
DC66554 | AdemC-GalNAc Phosphoramidite Featured | |
DC66555 | GalNAc-L96 Linker-Acid Featured | |
DC66556 | GalNAc PEG Cluster Phosphoramidite Featured |